Zota Health Care Ltd. · NSE:ZOTA
Zota Health Care — Q4 FY25 Earnings Presentation
52 slides from Zota Health Care's earnings presentation, May 30, 2025
Slide 1: Regulation 30 cover letter to NSE
May 30, 2025 To, The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/Madam, Trading Symbol: ZOTA Sub: Investor Presentation Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)
Slide 2: India's Largest Private Generic Pharmacy Retail Chain
INDIA’S LARGEST PRIVATE GENERIC PHARMACY RETAIL CHAIN Zota Health Care Limited Q4FY25 / FY25 Investor Presentation
Slide 3: Safe Harbour
Safe Harbour 2 zotahealthcare.com This presentation has been prepared by the Zota Health Care Limited (the “Company”) only for information purpose to the stakeholders and does not contain any offer or invitation to subscribe the securities of the Company. No offering of securities shall be made exce
Slide 4: Company Overview
Company Overview
Slide 5: Zota Healthcare At a Glance
Zota Healthcare At a Glance 4 zotahealthcare.com davaindia.com • Zota Health Care Ltd., a publicly listed company on NSE, has established a Business Verticals significant footprint in the Indian healthcare sector since its inception in 2000. • Headquartered in Surat and employing over 470 dedicated
Slide 6: Our Journey
Our Journey 5 zotahealthcare.com davaindia.com 01 02 03 2000 2004 2010 2011 2017 2018 Zota Health Care - Acquired all brand Inaugurated an export- Commenced exports, Introduced Davaindia, a private Achieved ₹10+ Cr in Export Sales; davaindia.com Incorporated names of Sayona oriented formulations exp
Slide 7: Management Profile (1/2)
Management Profile ( 1 /2 ) 6 zotahealthcare.com davaindia.com K E TAN K U M AR Z O TA M O X E S H Z O TA S U J I T PAU L CHAIRMAN AND MANAGING DIRECTOR Group Chief Executive Officer NON-EXECUTIVE DIRECTOR davaindia.com Total Experience: 38+ Total Experience: 10+ Total Experience: 23+ • Holds a D-Ph
Slide 8: Management Profile (2/2)
Management Profile ( 2 /2 ) 7 zotahealthcare.com davaindia.com AD H E E S H M U K E R J I R AJ E S H K U M AR PRITHISH KUNDU SGM (South & North) – SGM - Information Technology G M - B2B, PCD & ET HICAL COCO & FOFO OPERATIONS davaindia.com Total Experience: 17 Years Total Experience: 21 Years Total E
Slide 9: Company Structure
Company Structure 8 zotahealthcare.com davaindia.com Zota Health Care Limited Step down subsidiary Davaindia Procurement in (Davaindia Health Mart listed entity (Listed entity) Supplying products at ALP* Limited) davaindia.com COCO (COCO# stores) FOFO Domestic Export (Sales to FOFO# stores) FOFO Sal
Slide 10: Business & Industry Overview
Business & Industry Overview
Slide 11: Business Verticals
Business Verticals 10 zotahealthcare.com davaindia.com R E V E N U E C O N T R IB U T I O N ( F Y 2 5 ) 1 1 .. D DAAV VAA II N NDD II A A • A Retail generic pharmacy chain providing quality generic medicines. Consolidated 02 Store variants 30% – 90% • Focuses only on private-label products in: Compa
Slide 12: India is amongst the Lowest Public Spenders
India is amongst the 11 zotahealthcare.com davaindia.com Lowest Public Spenders Medicines account for ~70% 17.00%** Population with household spending on health greater than 10% of total household budget. davaindia.com 6.67%# Population with household spending on health greater than 25% of total hou
Slide 13: Case Study – Savings on Davaindia margins
Case Study – Savings on Davaindia margins 12 zotahealthcare.com davaindia.com Indian Pharma Indian Pharma Company marketed by > Davaindia MNC 1 MNC 2 Same Tablet Tablet / Medicine Name Rosuvas – 10 mg Rosubest - 10 Rosuvastatin 10 Significant davaindia.com with same Molecule Rosuvastatin 10mg saving
Slide 14: Davaindia Quality Medication at Affordable Prices
Davaindia Quality Medication at Affordable Prices 13 zotahealthcare.com davaindia.com Industry update Same Quality, Davaindia sells generic medicines manufactured by the same producers as Total turnover of Affordable Price branded medicines. This ensures equivalent quality at a fraction of the cost.
Slide 15: Davaindia Generic Pharmacy
GENERIC PHARMACY _DAVAINDIA
Slide 16: Davaindia - Retail Pharmacy Chain data
Davaindia - Retail Pharmacy Chain data 15 zotahealthcare.com davaindia.com Revolutionizing the generic pharmacy industry with affordable, accessible, quality healthcare solutions through retail pharmacies’ chain. *As of 31st March 2025 1,582* davaindia.com 2000+ 852 730 2.44+ crores SKUs Total no. C
Slide 17: Davaindia - Operating Model
Davaindia - Operating Model 16 zotahealthcare.com davaindia.com Offers a cluster-based store 2,000+ SKUs with 70% medicinal model, optimizing products and 30% OTC Cloud-based software and Implementing a hyperlocal accessibility and products, with a special emphasis AI-based tools for real-time model
Slide 18: Davaindia - Eliminating traditional supply chain
Davaindia - Eliminating traditional supply chain 17 zotahealthcare.com davaindia.com By sourcing directly from manufacturers and selling straight to consumers, traditional pharma supply chain is eliminated & the cost benefits are transferred to the consumer Average consumer price davaindia.com ~75%
Slide 19: Davaindia – What are COCO Stores
Davaindia – What are COCO Stores 18 zotahealthcare.com davaindia.com COCO stores are modern walk-in stores providing a distinct contrast to traditional counter-based pharmacies enhancing customer satisfaction and loyalty. Rapid Expansion The time required to open a new COCO store has been significan
Slide 20: Davaindia – COCO Stores
Davaindia – COCO Stores 19 zotahealthcare.com davaindia.com davaindia.com
Slide 21: Davaindia - COCO Stores
Davaindia - COCO Stores 20 zotahealthcare.com davaindia.com COCO Company-Owned Company-Operated 852 Operated by wholly-owned subsidiary Operational Davaindia Health Mart Davaindia Health Mart Ltd 1 COCO stores davaindia.com 22 29 Enhancing Store Significant rent rationalization to 55 ₹ 32,000 p.m. i
Slide 22: Davaindia COCO - KPI's (1/2)
Davaindia COCO - KPI’s (1/2) 21 zotahealthcare.com davaindia.com No. of Stores Quarterly Footfall in lakhs davaindia.com 852 19.0 15.7 658 11.8 494 387 8.6 6.9 253 Q4 FY24 Q1 FY25 Q2 FY25 Q3FY25 Q4FY25 Q4 FY24 Q1 FY25 Q2 FY25 Q3 FY25 Q4FY25 As of 31st March 2025
Slide 23: Davaindia COCO - KPI's (2/2)
Davaindia COCO - KPI’s (2/2) 22 zotahealthcare.com davaindia.com Quarterly GMV ₹ lakhs Avg. Wallet Spend ₹ davaindia.com ₹ 4,297 ₹ 241 ₹ 238 ₹ 3,507 ₹ 229 ₹ 227 ₹ 224 ₹ 2,714 ₹ 2,050 ₹ 1,660 Q4 FY24 Q1 FY25 Q2 FY25 Q3 FY25 Q4FY25 Q4 FY24 Q1 FY25 Q2 FY25 Q3 FY25 Q4FY25
Slide 24: Younger COCO Stores to fuel growth
Younger COCO Stores to fuel growth 23 zotahealthcare.com davaindia.com Significant Young Store Network 852 297 Many of our stores are relatively new, still in the early stages of their lifecycle. Total COCO Stores COCO Stores <5m While currently modest in revenue, expected to grow multiple folds as
Slide 25: Store Opening Lifecycle – COCO
Store Opening Lifecycle – COCO 24 zotahealthcare.com davaindia.com 75 Days Days 00 02 04 06 08 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48 50 52 54 56 58 60 62 64 66 68 70 72 74 76 0 Documentation - Online davaindia.com Registration 0 Sign up fees 1 Signing process Store 4 Store layo
Slide 26: Same Store Growth – Stores
Same Store Growth – 234 Stores 25 zotahealthcare.com davaindia.com 3.22 3.29 2.97 davaindia.com 2.56 2,258 2,308 2,086 1,797 Q1FY25 Q2FY25 Q3FY25 Q4FY25 Total GMV (₹ lakhs) Average Per Store Per Month GMV (₹ lakhs) The average GMV (Gross Merchandise Value) per store per month increased from ₹2.56 la
Slide 27: Same Store Growth: Period-wise Analysis
Same Store Growth: Period-wise Analysis 26 zotahealthcare.com davaindia.com (36+ Months) (24+ Months) 6.42 4.39 5.28 3.62 Opening Period: 1 Apr 21 - 30 Jun 22 Opening Period: 1 Jul 22 - 31 Mar 23 davaindia.com Number of Stores: 30 Number of Stores: 54 22% 21% YoY YoY Apr-24 Mar-25 Apr-24 Mar-25 (15+
Slide 28: Revenue Growth Trajectory of New Stores
Revenue Growth Trajectory of New Stores 27 zotahealthcare.com davaindia.com 2,25,000 2,05,000 davaindia.com 1,95,000 1,75,000 1,80,000 1,64,000 1,46,000 1,26,000 1,03,000 76,000 1st Month 2nd Month 3rd Month 4th Month 5th Month 6th Month 7th Month 8th Month 9th Month 10th Month GMV (₹) • A new store
Slide 29: Davaindia – What are FOFO Stores
Davaindia – What are FOFO Stores 28 zotahealthcare.com davaindia.com Franchisee-Owned Franchisee-Operated (FOFO) davaindia.com FOFO stores employ an asset-light franchise model, Asset-light franchise contributing to the scalability and accessibility of our model product offerings. FOFO stores are co
Slide 30: Davaindia - FOFO Stores
Davaindia - FOFO Stores 29 zotahealthcare.com davaindia.com 11 730 FOFO Franchise Owned Franchise Operated Operational States No. of Stores 3 FOFO stores Uttar Pradesh 150 6 West Bengal 100 davaindia.com 5 Odisha 97 42 3 Madhya Pradesh 60 33 Gujarat 50 Haryana 42 26 150 11 Maharashtra 41 30 12 Delhi
Slide 31: Davaindia - FOFO Stores
Davaindia - FOFO Stores 30 zotahealthcare.com davaindia.com davaindia.com
Slide 32: Davaindia FOFO - KPI's (1/2)
Davaindia FOFO - KPI’s (1/2) 31 zotahealthcare.com davaindia.com No. of Stores Quarterly Footfall in lakhs davaindia.com 730 11.9 11.3 697 10.4 8.9 8.9 664 645 627 Q4 FY24 Q1 FY25 Q2 FY25 Q3 FY25 Q4FY25 Q4 FY24 Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25
Slide 33: Davaindia FOFO - KPI's (2/2)
Davaindia FOFO - KPI’s (2/2) 32 zotahealthcare.com davaindia.com Quarterly GMV ₹ lakhs Avg. Wallet Spend ₹ davaindia.com ₹ 3,385 ₹ 290 ₹ 3,161 ₹ 2,840 ₹ 2,608 ₹ 285 ₹ 2,465 ₹ 279 ₹ 278 ₹ 274 Q4 FY24 Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25 Q4 FY24 Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25
Slide 34: OTC Over-the-counter products
OTC Over- the -counter products 33 zotahealthcare.com davaindia.com Strategic Acquisition Acquired 56% stake in the Everyday Herbal Group*, licensed by the davaindia.com as a move towards Khadi and Village Industrial Commission, a strategic move towards backward integration backward integration. ~30
Slide 35: OTC – Products
34 zotahealthcare.com davaindia.com davaindia.com OTC – Products
Slide 36: Davaindia is Revolutionising the Indian Healthcare Scenario
Davaindia is Revolutionising the 35 zotahealthcare.com davaindia.com Indian Healthcare Scenario * davaindia.com ₹24,562 lacs ~60 % Gross Merchandise Value in FY25 Gross Margin in COCO format 1,582 30-90 % Fast growing FOFO & COCO store network* Savings to consumers on Generic medicines 3.07 Lacs sq.
Slide 37: Davaindia Competitive Edge
Davaindia Competitive Edge 36 zotahealthcare.com davaindia.com The USP of Davaindia: Affordable, Trustworthy, and Innovative Pharmacy Solutions BENEFITS TO THE CUSTOMERS BENEFITS TO THE FRANCHISEES davaindia.com Medicines priced at low MRP thereby ensuring Store operations and the supply chain effic
Slide 38: Healthy Repeats
Healthy Repeats 37 zotahealthcare.com davaindia.com Total Average (in %) davaindia.com With a strong base of 80% repeat customers, Davaindia demonstrates a high level of customer satisfaction and 80% loyalty. Repeat Customers 12% New Customers 08% Lost Customers
Slide 39: Higher Chronic category share
Higher Chronic category share 38 zotahealthcare.com davaindia.com 57% davaindia.com 55% 25% 27% 20% 16% Chronic OTC Other Chronic OTC Other CATEGORY MIX FY24 CATEGORY MIX FY25 Higher chronic share: A significant 57% of our revenue comes from chronic disease category, signalling high realization and
Slide 40: Supply Chain Management
Supply Chain Management 39 zotahealthcare.com davaindia.com • The Company has outsourced supply chain management to a third-party warehousing & logistics partner. davaindia.com • A state-of-art central warehousing & processing center has been built in Surat, in Phase 1. • Eventually the Company will
Slide 41: Domestic Operations
GENERIC PHARMACY 02 Domestic Operations
Slide 42: Domestic Operations
41 Domestic Operations zotahealthcare.com davaindia.com Domestic marketing has been the oldest business vertical for the Company and has remained its mainstay in the past. Until 2017, this vertical contributed most of the davaindia.com Company’s revenues. This business vertical distributes generic d
Slide 43: Export Operations
Expor t Operations
Slide 44: Export Operations
43 Expor t Operations zotahealthcare.com davaindia.com Our Exports business vertical, which started in 2010, serves clients in over 30 countries, mainly in the CIS, Latin America, Africa, and Asia. At its plant in Sachin, SEZ, the Company davaindia.com manufactures generic formulations for the dossi
Slide 45: Financial Overview
Financial Overview
Slide 46: Management Commentary
Management Commentary 45 zotahealthcare.com davaindia.com “FY2025 truly stood out as a milestone year for Davaindia, marked by meaningful progress in our mission to make affordable healthcare more accessible across India. A major highlight was the strong expansion of our Company-Owned Company-Operat
Slide 47: Quarterly Revenue Segmentation
Quar terly Revenue Segmentation 46 zotahealthcare.com davaindia.com Business Verticals – Consolidated Revenue bifurcation Davaindia ₹ lakhs Domestic Operations ₹ lakhs Export Operations ₹ lakhs davaindia.com 6,282 1,771 1,501 1,234 4,591 1,276 830 3,123 566 Q4 FY24 Q3 FY25 Q4 FY25 Q4 FY24 Q3 FY25 Q4
Slide 48: Annually Financial Snapshot
Annually Financial Snapshot 47 zotahealthcare.com davaindia.com Davaindia has driven revenue growth, recording an impressive increase of ~ 65% CAGR since FY22. Business Verticals – Consolidated Revenue bifurcation davaindia.com Davaindia ₹ lakhs Domestic Operations ₹ lakhs Export Operations ₹ lakhs
Slide 49: Business Vertical Performance (Consolidated)
Business Ver tical Performance ( C o n s o l i d a t e d ) 48 zotahealthcare.com davaindia.com ₹ in lakhs (Consolidated) Q4 FY25 Particulars Business Vertical Davaindia Domestic Exports Everyday davaindia.com Revenue from Operation 6281.7 1771.1 1233.7 441.0 Cost of Goods Sold 2632.0 1213.2 633.6 30
Slide 50: Profit & Loss Statement (Consolidated)
Profit & Loss Statement ( C o n s o l i d a t e d ) 49 zotahealthcare.com davaindia.com ₹ in lakhs (Consolidated) Particulars Q4FY25 Q3FY25 Q4FY24 FY25 FY24 Export Sales (SEZ) 1233.7 829.88 565.9 3190.3 2,003.5 Davaindia Sales 6281.7 4590.85 3122.6 18621.4 10,355.9 davaindia.com Domestic Sales 1771.
Slide 51: Balance Sheet statement
Balance Sheet statement 50 zotahealthcare.com davaindia.com ₹ in lakhs (Consolidated) As at As at As at As at ASSETS 31st March 31st March EQUITY AND LIABILITIES 31st March 31 March 2025 2024 2025 2024 Non-Current Assets (i) Equity Share capital 2,863.5 2,584.7 davaindia.com Property, plant and equi
Slide 52: Thank You
Thank You Contact Infor mation M r. Ashvin Variya "ZOTA HOUSE", 2/896, Hira Modi Street, Sagrampura, Surat-395 002 (Gujarat) cszota@zotahealthcare.com www.zotahealthcare.com EY LLP Siddesh Chawan - siddesh.chawan@in.ey.com Ajit Mishra- ajit.j.mishra@in.ey.com www.ey.com